Hoffman Michael B
- SEC CIK
- 0001290208
In the past year, 7 open-market purchase filings worth $7.10M and no sales.
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $7.10M
- 7 filings
- Sold
- –
- 0 filings
- Net
- +$7.10M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hoffman Michael B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ANVS Annovis Bio, Inc.
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 (view filing)4:30 PM ET | Nov 6 | Same day | Hoffman Michael BDirector | PPurchase | +5.00M | $1.00 | +$5.00M | +148.6%8.36M after | |
| Nov 6, 2026 (view filing)4:30 PM ET | Nov 6 | Same day | Hoffman Michael BDirector | PPurchase | +5.00M | $0.00 | $0 | –5.00M after | Derivative |
| May 21, 2026 (view filing) | May 20 | 1 day | Hoffman Michael BDirector | PPurchase | +76.3K | $1.87 | +$142.8K | +2.3%3.36M after | 3 lots |
| Apr 3, 2026 (view filing) | Apr 2 | 1 day | Hoffman Michael BDirector | PPurchase | +713.8K | $2.10 | +$1.50M | +27.7%3.29M after | |
| Dec 8, 2025 (view filing) | Dec 8 | Same day | Hoffman Michael BDirector | PPurchase | +45.0K | $4.31 | +$193.8K | +1.8%2.57M after | 2 lots |
| Nov 25, 2025 (view filing) | Nov 24 | 1 day | Hoffman Michael BDirector | PPurchase | +39.2K | $4.08 | +$159.9K | +1.6%2.53M after | Amended4 lots |
| Nov 21, 2025 (view filing) | Nov 21 | Same day | Hoffman Michael BDirector | PPurchase | +20.0K | $3.50 | +$69.9K | +0.8%2.49M after | 2 lots |
| Nov 18, 2025 (view filing) | Nov 14 | 4 days | Hoffman Michael BDirector | PPurchase | +15.0K | $2.11 | +$31.6K | +0.6%2.47M after | |
| Nov 12, 2025 (view filing) | Oct 28 | 15 daysLate | Hoffman Michael BDirector | PPurchase | +975.6K | $2.05 | +$2.00M | +65.9%2.46M after |
TDAC Translational Development Acquisition Corp.
Chairman and CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 (view filing) | May 27 | 2 days | Hoffman Michael BChairman and CEO | PPurchaseClass A ordinary shares | +53.4K | $0.79 | +$42.2K | –53.4K after | Derivative |